Clinical trial
Interleukin-1 Receptor Antagonist Gene Polymorphism and Adverse Pregnancy Outcome in Turkish Women
NCT01812083 is registered in ClinicalTrials.gov with Selcuk University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interleukin-1 Receptor Antagonist Gene Polymorphism and Adverse Pregnancy Outcome in Turkish Women
- Lead sponsor
- Selcuk University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- February 28, 2005
- Enrollment
- 156 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.